System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Eberhart Zrenner is an expert in Ophthalmology at University of Tübingen (Germany). As of March 2026, ScienceLeadR ranks Eberhart Zrenner in the top 1% of experts worldwide for Vision Disorders and Eye Diseases, Hereditary. Eberhart Zrenner has authored 731 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 1 of them ongoing. SLR score: 1,907 (community average: 125). How the SLR is computed.

LeadR Profile

Eberhart Zrenner University of Tübingen Germany
1 907 ScienceLeadR Reputation 1907

Unlock

Register Login
Network Map

Ophthalmology

Subspecialties: Biochemistry - Physical Medicine - Psychology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1990 - 2026
Source: PubMed

University of Tübingen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 731

Citations

Citations: 28 375 1st author: 47 Last author: 269 Unique author: 20

Main journals

Invest Ophthalmol Vis Sci 159
Vision Res 45
Doc Ophthalmol 40
Ophthalmologe 31
Graefes Arch Clin Exp Ophthalmol 29

Best Journals

Science 2
Lancet 1
Nat Photonics 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Longitudinal Changes of Fundus Autofluorescence and Correlation With Visual Acuity in ABCA4-Associated Stargardt Disease.
PMID 41773771 — eye, growth, stargardt disease, ophthalmology, visual acuity		Invest Ophthalmol Vis Sci20260
Surgical Approach for the Implantation of a Ring Electrode into the Sulcus in a Phakic Non-human Primate.
PMID 41665323 — eye, biomimetics, muscles, electrodes, refractive surgical procedures, iris		J Refract Surg20260
Real-Time Control of a Focus Tunable Lens for Presbyopia Correction Using Ciliary Muscle Biopotentials and Artificial Neural Networks.
PMID 41301185 — eye, muscles, machine learning, presbyopia, work		Bioengineering (Basel)20250
Natural History of Autosomal Recessive IMPG2-Associated Retinal Dystrophy.
PMID 40484299 — retinal dystrophies, natural history, genetics, visual acuity, tomography, optical coherence, retinitis pigmentosa, history, retinaldehyde, age of onset		Am J Ophthalmol20251
Safety and vision outcomes of subretinal gene supplementation therapy in PDE6A-associated retinitis pigmentosa: a non-randomised controlled trial.
PMID 40825661 — retinitis, genes, vision, ocular, safety, ophthalmology, drug-related side effects and adverse reactions, visual acuity, retinitis pigmentosa, therapeutics, retinaldehyde		Br J Ophthalmol20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Chair: 1

By phase:

N/A 5
Phase 1/Phase 2 2
Phase 1 1
Phase 2 1

By status:

Completed 6
Recruiting 2
Active not recruiting 1

By type:

Interventional 7
Observational 2

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 3
multicentric5to9 3
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study of BEST1 Vitelliform Macular Dystrophy
NCT05809635 — eye, retinitis, macular degeneration, genes, bestrophins, natural history, retinitis pigmentosa, therapeutics, history, mutation, vitelliform macular dystrophy		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS